Schedule 13G ownership disclosure
Tobira Therapeutics Inc
Security class unavailable · CUSIP: 88883P101
Event date: 2015-05-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.8100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-190675
- Form type
- SC 13G
- Filer
- Montreux Equity Partners IV, L.P.
- CIK
- CIK 1456153
- Filed
- May 18, 2015
- Reporting period
- May 04, 2015
- Description
- Schedule 13G beneficial ownership